← stocks-llm Find companies like ZTS →

Zoetis (ZTS)

Health Care

Global animal health company delivering vaccines, parasiticides, diagnostics and pharmaceuticals for companion animals and livestock.

What Zoetis does

Zoetis develops, manufactures and markets a diverse portfolio of animal health products across the continuum of care for companion animals (about 70% of revenue) and livestock (about 29%). The company offers approximately 300 product lines spanning vaccines, parasiticides, dermatology products, anti-infectives, pain management, diagnostics and other therapeutics. Its products help veterinarians treat disease, extend pet longevity, improve farm productivity and support food security globally.

Themes: ["companion animal health","livestock productivity","food security","pet care spending","veterinary diagnostics","flea and tick prevention","vaccine development","animal disease prevention"]

Fundamentals

Dividend: yield +1.6%; 5-year non-decreasing per-share dividend streak (SEC XBRL).

Ask why ZTS looks like this →

Key risks (from latest filing)

["Revenue growth slowed to 2.4% YoY and net income declined slightly; market sensitivity to pet spending and livestock disease cycles could further impact growth","Strong debt position at $9.045 billion limits financial flexibility; recent divestiture of medicated feed additive portfolio signals portfolio optimization challenges","Stock price declined 51.4% over the past year despite profitability, indicating investor concerns about growth prospects, competitive pressures or market conditions in animal health"]

See ZTS's biggest risks from its latest 10-Q →

Competitors & peers

Not quite? Describe exactly what you want →

Fundamentals: Finnhub, as of 2026-07-09. Filings: SEC EDGAR. Prices are delayed daily-close data.

Last updated 2026-07-08.

Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.